Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Released by Interventional Approaches for Advanced Solid Tumors

Study Summary

To study the safety and clinical effects of intratumor injecting CpG-ODN and in situ release of tumor antigen by interventional ablation or drug-eluting beads to treat advanced solid tumors.

Interventions

Study Locations

Facility	City	State	Country
The Second Affiliated Hospital of Guangzhou Medical University	Guangzhou	Guangdong	China

Official Trial Information

View on ClinicalTrials.gov